Prothena Reports Second Quarter 2021 Financial Results and Business Highlights

Retrieved on: 2021-08-05 20:03:45

Tags for this article:

Click the tags to see associated articles and topics

Prothena Reports Second Quarter 2021 Financial Results and Business Highlights. View article details on hiswai:

Excerpt

$60 million milestone from Roche for prasinezumab received in 2Q 2021; $80 million milestone from Bristol Myers Squibb for PRX005 expected in 3Q ...

Article found on: www.globenewswire.com